Anna Rita Maurizi - Universita Campus Bio-Medico di Roma

基本信息

Career Trajectory

Bio

Anna Rita Maurizi currently works at the Endocrinology and Diabetes Unit, Universita Campus Bio-Medico di Roma. Anna does research in Diabetology, Internal Medicine (General Medicine) and Nutrition and Dietetics. Her most recent publication is 'A Novel Three‐Compartmental Model for Artificial Pancreas: Development and Validation.'

Research Interests

Papers共 37 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Generalizability and Treatment with Sodium-Glucose Co-Trasporter-2 Inhibitors (sglt2i) among Patients with Type 2 Diabetes: an Assessment Using an Italian Primary Care Database

Ippazio Cosimo Antonazzo,Davide Rozza,Paolo Angelo Cortesi,Carla Fornari, Elena Zanzottera Ferrari,Claire Paris,Caroline Eteve-Pitsaer, Marco Gnesi, Silvia Mele, Marco D’Amelio,Anna Rita Maurizi, Pasquale Palladino,Lorenzo Giovanni Mantovani,Giampiero Mazzaglia

Acta Diabetologicapp.1-9, (2024)

Cited0Views0WOSBibtex

Clinical and Economic Impact of Early Diagnosis of Chronic Kidney Disease in General Practice: the Endorse Study

Francesco Pesce,Giacomo Matteo Bruno,Giorgio Lorenzo Colombo,Sergio Di Matteo,Anna Rita Maurizi, Valentina Mongelli, Silvia Mele, Lavinia Narici,Stefano Bianchi,Mario Bonomini, Giuseppe Castellano, Luca De Nicola,Giovanni Gambaro,Giuseppe Grandaliano,Gaetano La Manna,Antonello Pani,Andrea Ranghino,Loreto Gesualdo

CLINICOECONOMICS AND OUTCOMES RESEARCH (2024): 547-555

Cited0Views0WOSBibtex

Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial

Lorenzo Piemonti,Bart Keymeulen,Pieter Gillard,Thomas Linn,Emanuele Bosi,Ludger Rose,Paolo Pozzilli,Francesco Giorgino,Efisio Cossu,Luisa Daffonchio,Giovanni Goisis,Pier Adelchi Ruffini,Anna Rita Maurizi,Flavio Mantelli,Marcello Allegretti

DIABETES OBESITY & METABOLISM（2022）

Cited13Views0WOSBibtex

Author response for "Ladarixin, an inhibitor of <scp>IL</scp> ‐8 receptors <scp>CXCR1</scp> and <scp>CXCR2</scp> , in new‐onset type 1 diabetes: a multicenter, randomized, double‐blind, placebo‐controlled trial"

Lorenzo Piemonti, Bart Keymeulen, Pieter Gillard, Thomas Linn, Emanuele Bosi, Ludger Rose, Paolo Pozzilli, Francesco Giorgino, Efisio Cossu, Luisa Daffonchio, Giovanni Goisis, Pier Adelchi Ruffini, Anna Rita Maurizi, Flavio Mantelli, Marcello Allegretti

crossref（2022）

Cited0Views0Bibtex

Ladarixin, an inhibitor of IL ‐8 receptors CXCR1 and CXCR2 , in new‐onset type 1 diabetes: a multicenter, randomized, double‐blind, placebo‐controlled trial

Lorenzo Piemonti,Bart Keymeulen,Pieter Gillard,Thomas Linn,Emanuele Bosi,Ludger Rose,Pozzilli Paolo,Francesco Giorgino,Efisio Cossu,Luisa Daffonchio,Giovanni Goisis,Pier Adelchi Ruffini,Anna Rita Maurizi,Flavio Mantelli, Marcello Allegretti

Diabetes, Obesity and Metabolism (2022)

Cited13Views0Bibtex

Author Response for "ladarixin, an Inhibitor of <scp>il</scp> ‐8 Receptors <scp>cxcr1</scp> and <scp>cxcr2</scp> , in New‐onset Type 1 Diabetes: a Multicenter, Randomized, Double‐blind, Placebo‐controlled Trial"

Lorenzo Piemonti, Bart Keymeulen,Pieter Gillard,Thomas Linn,Emanuele Bosi,Ludger Rose,Paolo Pozzilli, Francesco Giorgino,Efisio Cossu, L. Daffonchio,Giovanni Goisis,Pier Adelchi Ruffini,Anna Rita Maurizi,Flavio Mantelli,Marcello Allegretti

openalex（2022）

Cited0Views0Bibtex

1217-P: Improvement of Metabolic Control in Type 1 Diabetes after Transition Is Independent from Referral Center and Insulin Regimen

Silvia Pieralice,Ernesto Maddaloni,Chiara Moretti,Anna Rita Maurizi,Carmen Mignogna, Stefano Dinatale,Paolo Pozzilli,Raffaella Buzzetti

Diabetes（2020）

Cited0Views0Bibtex

1581-P: Increase of Diabetes and Obesity among Descendants of First-Generation Filipino Immigrants to Italy

Silvia Pieralice,Rossella Del Toro,Yeganeh Manon Khazrai,Ernesto Maddaloni,Anna Rita Maurizi,Silvia Manfrini,Paolo Pozzilli

Diabetes（2019）

Cited0Views0Bibtex

Il Trattamento Del Diabete Di Tipo 1: Dalle Nuove Insuline Ai Farmaci Orali

Anna Rita Maurizi,Silvia Pieralice,Paolo Pozzilli

L'Endocrinologono. 1 (2019): 21-26

Cited0Views0Bibtex

Biomarkers of Response to Alpha-Lipoic Acid ± Palmitoiletanolamide Treatment in Patients with Diabetes and Symptoms of Peripheral Neuropathy

Silvia Pieralice, Riccardo Vari, Alessandra Minutolo,Anna Rita Maurizi,Elvira Fioriti,Nicola Napoli,Paolo Pozzilli,Silvia Manfrini,Ernesto Maddaloni

Endocrine（2019）

Cited13Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn